Brief: SinoMab Bioscience Says IND Application For SN1011 Filed With And Accepted By Center For Drug Evaluation Of NMPA
07/02/2022 10:38
Feb 7 (Reuters) - SinoMab BioScience Ltd 3681.HK :
* IND APPLICATION FOR SN1011 FILED WITH AND ACCEPTED BY
CENTER FOR
DRUG EVALUATION OF NMPA
Further company coverage: 3681.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sinomab Bioscience
See all newsBrief: Sinomab Bioscience Posts HY Loss Of RMB127.4 Million
Brief: Sinomab Bioscience Says Fang Liang Resigns As Executive Director
Brief: Sinomab Bioscience Announces Major Deal For Disposal Of Suzhou Property And Facility For RMB280 MLN
Brief: SinoMab Bioscience Appoints Fang Liang As Executive Director
Brief: Hainan Haiyao Plans To Unload Stake In Sinomab Bioscience